- Home
- ALZN vs MITQ Comparison
ALZN vs MITQ Comparison
Compare ALZN & MITQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALZN
- MITQ
- Stock Information
- Founded
- ALZN 2016
- MITQ N/A
- Country
- ALZN United States
- MITQ United States
- Employees
- ALZN N/A
- MITQ N/A
- Industry
- ALZN Medicinal Chemicals and Botanical Products
- MITQ Telecommunications Equipment
- Sector
- ALZN Health Care
- MITQ Telecommunications
- Exchange
- ALZN Nasdaq
- MITQ Nasdaq
- Market Cap
- ALZN 7.0M
- MITQ 6.7M
- IPO Year
- ALZN 2021
- MITQ 2021
- Fundamental
- Price
- ALZN $1.11
- MITQ $0.68
- Analyst Decision
- ALZN Strong Buy
- MITQ
- Analyst Count
- ALZN 1
- MITQ 0
- Target Price
- ALZN $32.00
- MITQ N/A
- AVG Volume (30 Days)
- ALZN 174.7K
- MITQ 21.4K
- Earning Date
- ALZN 12-31-2024
- MITQ 02-12-2025
- Dividend Yield
- ALZN N/A
- MITQ N/A
- EPS Growth
- ALZN N/A
- MITQ N/A
- EPS
- ALZN N/A
- MITQ N/A
- Revenue
- ALZN N/A
- MITQ $18,756,000.00
- Revenue This Year
- ALZN N/A
- MITQ N/A
- Revenue Next Year
- ALZN N/A
- MITQ N/A
- P/E Ratio
- ALZN N/A
- MITQ N/A
- Revenue Growth
- ALZN N/A
- MITQ N/A
- 52 Week Low
- ALZN $1.06
- MITQ $0.42
- 52 Week High
- ALZN $15.06
- MITQ $1.44
- Technical
- Relative Strength Index (RSI)
- ALZN 34.55
- MITQ 55.17
- Support Level
- ALZN $1.16
- MITQ $0.64
- Resistance Level
- ALZN $1.33
- MITQ $0.74
- Average True Range (ATR)
- ALZN 0.09
- MITQ 0.04
- MACD
- ALZN 0.01
- MITQ -0.00
- Stochastic Oscillator
- ALZN 17.86
- MITQ 53.42
About ALZN Alzamend Neuro Inc.
Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipeline consists of two novel therapeutic drug candidates, AL001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and AL002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's.
About MITQ Moving iMage Technologies Inc.
Moving iMage Technologies Inc is engaged in providing designed equipment as well as other off the shelf cinema products needed for contemporary cinema requirements. It offers technical, design and consulting services such as custom engineering, systems design, integration and installation and digital technology, as well as software solutions for operations enhancement and theatre management.